Safety and Efficacy of Sertraline for Depression in Patients with CHF (SADHART-CHF): A Randomized, Double-Blind, Placebo-Controlled Trial of Sertraline for Major Depression with Congestive Heart Failure

BACKGROUND: Sertraline, a selective serotonin-reuptake inhibitor (SSRI), has demonstrated substantial mood improvement in patients with post myocardial infarction or with unstable angina. The impact of sertraline on the prognosis and depression of patients with chronic heart failure (HF) and co-morb...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Jiang, Wei, O’Connor, Christopher, Silva, Susan G., Kuchibhatla, Maragatha, Cuffe, Michael S., Callwood, Dwayne D., Zakhary, Bosh, Henke, Elizabeth, Arias, Rebekka M, Krishnan, Ranga
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2659472/
https://ncbi.nlm.nih.gov/pubmed/18760123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2008.05.003
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki